by Frank Bergman, Slay News:
A major new study involving 9 million people has confirmed that Covid mRNA “booster” shots cause surges in deaths, hospitalizations, a diagnoses of deadly diseases.
Alarmingly, the study also found that people who received the so-called “boosters” were more likely to become infected with COVID-19.
The study, led by Professor George N. Ioannou from the University of Washington in Seattle, was published in the Annals of Internal Medicine.
TRUTH LIVES on at https://sgtreport.tv/
The research was performed by teams from the University of Washington, the Yale School of Medicine, the Yale School of Public Health, Oregon State University, the University of Michigan, and various Veterans Affairs regional departments.
The study was conducted in collaboration with the U.S. Veterans Health Administration (VHA).
Marking one of the largest Covid “vaccines” studies to date, the researchers analyzed the VHA electronic health record data system.
During their study, the researchers analyzed the data of over 9 million veterans.
After reviewing the vast data in the VHA system, the study found that people who received a “booster” mRNA “vaccine” for Covid in 2023 and 2024 were more likely to get Covid, be admitted to hospital, or die.
They analyzed data from VHA’s comprehensive electronic health record system to compare outcomes between people who had received the booster and those who hadn’t.
The researchers found that vaccine efficacy against COVID-19 infection was -3.26%, indicating “a statistically significant higher infection rate in vaccinated individuals compared to the unvaccinated control group,” according to leading epidemiologist Nicolas Hulscher, who reported on the study.
They also found increases in hospitalization and death among those who had taken the “vaccine.”
“Our findings call for accelerated efforts to develop new vaccination strategies that could provide higher and more sustained protection in the current era of COVID-19,” the researchers concluded.
The U.S. Food and Drug Administration (FDA) approved the boosters before clinical trials for efficacy were conducted.
